TVGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGNW
Tevogen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$6.77−0.30 (-4.24%)
Close on Oct 19, 2026
- Market cap
- $25.92M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$28.31 (−80.70%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $25.92M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -47.80%
Fundamentals
- Net income
- -$21.61M
- EPS, diluted
- -$6.98
- Free cash flow
- -$12.39M
- Book value per share
- -$2.32
- Diluted shares
- 4M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
-$21.40M
Net income
-$21.61M
EPS, diluted
-$6.98
Free cash flow
–
Reported periodTrailing twelve months